Organocatalytic asymmetric reduction of <i>N</i>-unsubstituted -enamino ester with HSiCl<sub>3</sub>

Yushi Liang,Yumeng Liang,Jingwen Chen,Mingjie Liu,Zhenghua Zhao,Zongbi Bao,Qiwei Yang,Qilong Ren,Zhiguo Zhang
DOI: https://doi.org/10.1016/j.tetlet.2023.154492
IF: 2.032
2023-01-01
Tetrahedron Letters
Abstract:The asymmetric reduction of N-unsubstituted beta-enamino esters is the key step for catalytic asymmetric construction of sitagliptin, a prevalent drug for the treatment of type 2 diabetes. However, it is still lack of environment friendly, low-cost, nontoxic, and highly selective catalysts. Herein, we report a series of new silyl ether substituted L-pipecolinic formamides organocatalysts for the asymmetric reduction of Nunsubstituted beta-enamino esters with trichlorosilane as the reducing agent. The steric hindrance of silyl ether substitutes can remarkably influence the catalytic performance. The optimized triphenylsilyl substituted catalyst 2k can efficiently catalyze the reduction reaction, affording enantioenriched beta-amino ester with excellent yield (95 %) and high ee (82 %). (C) 2023 Elsevier Ltd. All rights reserved.
What problem does this paper attempt to address?